An immunogenic composition comprising influenza virus haemagglutinin andmatrix proteins. These may be from influenza viruses grown in cell culture ratherthan eggs. The matrix protein may be a fragment of a full-length viral matrix proteine.g. a matrix M1 fragment with a molecular weight of less than 2OkDa. The compositionmay be a subunit vaccine comprising purified surface glycoproteins.
